{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:58:22Z","timestamp":1648868302905},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:p>The success of human papilloma virus (HPV) screening is attributable to clear-cut guidelines on the detection and management of premalignant HPV lesions. A similar approach is necessary for both low-risk and high-risk lesions, including anogenital warts.<\/jats:p>","DOI":"10.1634\/theoncologist.2016-0379","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T01:12:05Z","timestamp":1491354725000},"page":"495-496","source":"Crossref","is-referenced-by-count":0,"title":["Controlling Human Papilloma Virus: A Public Health Perspective of Treatment of Anogenital Warts"],"prefix":"10.1093","volume":"22","author":[{"given":"Nadeem","family":"Tanveer","sequence":"first","affiliation":[{"name":"Department of Pathology, University College of Medical Sciences University of Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"2021122507531813700_onco12087-bib-0001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/LGT.0b013e3181f515a2","article-title":"Invasive cervical cancer and screening: What are the rates of unscreened and underscreened women in the modern era?","volume":"15","author":"Subramaniam","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"2021122507531813700_onco12087-bib-0002","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/jcm4050918","article-title":"Current cervical carcinoma screening guidelines. Grant-Kels","volume":"4","author":"Schlichte","year":"2015","journal-title":"J, ed. J Clin Med"},{"key":"2021122507531813700_onco12087-bib-0003","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"(3 suppl 1)","key":"2021122507531813700_onco12087-bib-0004","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"key":"2021122507531813700_onco12087-bib-0005","doi-asserted-by":"crossref","first-page":"211.e9","DOI":"10.1016\/j.urology.2012.09.009","article-title":"Occurrence of dysplasia and human papilloma virus typing in penile condylomas","volume":"81","author":"Baydar","year":"2013","journal-title":"Urology"},{"key":"2021122507531813700_onco12087-bib-0006","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4111\/kju.2014.55.3.207","article-title":"Prevalence and determinants of high-risk human papillomavirus infection in male genital warts","volume":"55","author":"Park","year":"2014","journal-title":"Korean J Urol"},{"key":"2021122507531813700_onco12087-bib-0007","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","article-title":"Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years","volume":"31","author":"Jin","year":"2016","journal-title":"J Gen Intern Med"},{"key":"2021122507531813700_onco12087-bib-0008","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3892\/ol.2016.4903","article-title":"HPV strain distribution in patients with genital warts in a female population sample","volume":"12","author":"Boda","year":"2016","journal-title":"Oncol Lett"},{"key":"2021122507531813700_onco12087-bib-0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2340\/00015555-1718","article-title":"Prevalence of human papillomavirus in anal and oral sites among patients with genital warts","volume":"94","author":"Kofoed","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"2021122507531813700_onco12087-bib-0010","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/infdis\/jis228","article-title":"Genital warts and risk of cancer: A Danish study of nearly 50 000 patients with genital warts","volume":"205","author":"Blomberg","year":"2012","journal-title":"J Infect Dis"},{"key":"2021122507531813700_onco12087-bib-0011","first-page":"141","article-title":"Human papillomavirus in oropharyngeal cancer: The changing face of a disease","volume":"1866","author":"Mallen-St Clair","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2021122507531813700_onco12087-bib-0012","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122507531813700_onco12087-bib-0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/14787210.2016.1174065","article-title":"Anal human papillomavirus infection: Prevalence, diagnosis and treatment of related lesions","volume":"14","author":"Benevolo","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021122507531813700_onco12087-bib-0014","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(16)31266-1","article-title":"Expanding the benefits of HPV vaccination to boys and men","volume":"388","author":"Doiron","year":"2016","journal-title":"Lancet."},{"key":"2021122507531813700_onco12087-bib-0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cct.2016.10.006","article-title":"Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine","volume":"52","author":"Luxembourg","year":"2017","journal-title":"Contemp Clin Trials"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2016-0379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2016-0379","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/5\/495\/41915843\/oncolo_22_5_495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/5\/495\/41915843\/oncolo_22_5_495.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T07:54:38Z","timestamp":1640418878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/22\/5\/495\/6438881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,4,4]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2016-0379","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,4,4]]}}}